Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,300 | 5 | 29.7% |
| Food and Beverage | $14,247 | 515 | 26.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,552 | 35 | 24.7% |
| Travel and Lodging | $10,661 | 21 | 19.4% |
| Education | $86.27 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $19,189 | 90 | $0 (2024) |
| Allergan, Inc. | $17,532 | 117 | $0 (2023) |
| Aclaris Therapeutics, Inc. | $5,620 | 21 | $0 (2019) |
| Merz North America, Inc. | $3,280 | 23 | $0 (2023) |
| ABBVIE INC. | $3,206 | 87 | $0 (2024) |
| GENZYME CORPORATION | $1,355 | 35 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $867.25 | 17 | $0 (2024) |
| Incyte Corporation | $636.34 | 29 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $524.87 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $519.17 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,676 | 117 | ABBVIE INC. ($1,941) |
| 2023 | $3,054 | 97 | ABBVIE INC. ($715.65) |
| 2022 | $11,227 | 87 | Galderma Laboratories, L.P. ($4,941) |
| 2021 | $8,222 | 65 | Allergan, Inc. ($7,333) |
| 2020 | $475.11 | 16 | MERZ NORTH AMERICA, INC. ($278.33) |
| 2019 | $15,769 | 102 | Galderma Laboratories, L.P. ($9,409) |
| 2018 | $4,490 | 60 | Galderma Laboratories, L.P. ($3,253) |
| 2017 | $6,934 | 38 | Allergan Inc. ($5,389) |
All Payment Transactions
582 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $1.67 | General |
| 12/10/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $9.26 | General |
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/22/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $49.86 | General |
| Category: Immunology | ||||||
| 11/21/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $1.57 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.16 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $34.80 | General |
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $49.49 | General |
| Category: Immunology | ||||||
| 11/10/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $135.92 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/07/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $31.80 | General |
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Immunology | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $49.93 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $6.01 | General |
| 10/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.72 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Immunology | ||||||
| 10/10/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $130.04 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $14.35 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 3,698 | 8,411 | $1.4M | $681,510 |
| 2022 | 27 | 2,676 | 4,833 | $404,328 | $242,751 |
| 2021 | 26 | 2,452 | 9,938 | $320,483 | $210,817 |
| 2020 | 27 | 3,360 | 15,126 | $362,553 | $234,947 |
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 30 | 581 | $271,908 | $123,764 | 45.5% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 31 | 607 | $188,777 | $88,798 | 47.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 610 | 809 | $107,561 | $69,917 | 65.0% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 103 | 114 | $164,651 | $53,198 | 32.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 328 | 393 | $46,701 | $32,952 | 70.6% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 58 | 69 | $83,366 | $32,915 | 39.5% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 59 | 87 | $75,559 | $29,161 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 337 | 425 | $39,646 | $27,068 | 68.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 314 | 372 | $40,058 | $24,591 | 61.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 433 | 595 | $43,633 | $21,953 | 50.3% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 23 | 62 | $25,277 | $19,005 | 75.2% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 31 | 562 | $39,902 | $18,243 | 45.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 118 | 138 | $24,563 | $17,798 | 72.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 350 | 2,552 | $18,769 | $12,621 | 67.2% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 49 | 56 | $48,802 | $11,623 | 23.8% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 46 | 48 | $53,087 | $9,811 | 18.5% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 19 | 41 | $12,550 | $9,236 | 73.6% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 15 | 15 | $28,139 | $9,081 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $15,818 | $8,703 | 55.0% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 17 | 21 | $15,486 | $6,741 | 43.5% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 24 | 25 | $23,544 | $6,331 | 26.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 23 | 26 | $8,390 | $6,322 | 75.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 96 | 151 | $8,075 | $6,050 | 74.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 100 | 111 | $6,926 | $4,733 | 68.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $7,045 | $4,409 | 62.6% |
About Dr. Anna Pare', M.D
Dr. Anna Pare', M.D is a Dermatology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437135274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Pare', M.D has received a total of $54,847 in payments from pharmaceutical and medical device companies, with $4,676 received in 2024. These payments were reported across 582 transactions from 35 companies. The most common payment nature is "Consulting Fee" ($16,300).
As a Medicare-enrolled provider, Pare' has provided services to 12,186 Medicare beneficiaries, totaling 38,308 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Atlanta, GA
- Active Since 12/22/2005
- Last Updated 01/27/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1437135274
Products in Payments
- ESKATA (Drug) $5,564
- DUPIXENT (Biological) $1,382
- Xeomin (Biological) $1,055
- DAXXIFY (Drug) $867.25
- SKYRIZI (Biological) $777.73
- OPZELURA (Drug) $636.34
- Sotyktu (Drug) $431.89
- RINVOQ (Biological) $399.74
- BOTOX COSMETIC (Biological) $326.40
- COSENTYX (Biological) $263.27
- TALTZ (Drug) $230.38
- EUCRISA (Drug) $216.54
- BOTOX (Biological) $212.05
- XEOMIN (Biological) $180.19
- COSENTYX (Drug) $158.25
- LIBTAYO (Biological) $124.23
- BLU-U (Medical Supply) $117.21
- VTAMA (Drug) $111.02
- ENSTILAR (Drug) $83.99
- Winlevi (Drug) $69.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Atlanta
Dr. Zakiya Rice, Md, MD
Dermatology — Payments: $920,568
Dr. Mack Rachal, M.d, M.D
Dermatology — Payments: $478,485
Sarah Chisolm, M.d, M.D
Dermatology — Payments: $44,095
Ron Feldman, Md, Phd, MD, PHD
Dermatology — Payments: $38,217
Lauren Orenstein, Md, MD
Dermatology — Payments: $27,645
Dr. Suephy Chen, Md, MD
Dermatology — Payments: $19,150